03 9.49E-03 four.54E-03 9.12E-03 1.09E-02 5.70E-06 1.16E-02 1.17E-02 1.24E-02 1.26E-02 7.21E-03 2.70E-

Материал из Wiki портал КГАУ "КЦИОКО"
Перейти к: навигация, поиск

03 9.49E-03 four.54E-03 9.12E-03 1.09E-02 5.70E-06 1.16E-02 1.17E-02 1.24E-02 1.26E-02 7.21E-03 2.70E-03 4.92E-04 9.81E-01 two.22E-02 two.30E-02 3.32E-03 1.21E-02 2.46E-02 three.00E-06 4.77E-02 1.42E-02 4.08E-03 2.94E-02 3.25E-02 four.15E-02 0.00E+00 0.00E+00 4.55E-08 0.00E+00 4.47E-04 9.38E-04 9.60E-01 1.12E-03 1.95E-05 three.94E-05 1.73E-03 3.22E-29 1.77E-21 two.50E-03 1.27E-05 1.42E-05 three.98E-14 two.63E-03 2.79E-03 three.07E-03 three.22E-03 1.71E-10 1.45E-04 five.66E-03 four.91E-03 1.48E-18 1.23E-02 9.94E-04 1.34E-02 0.00E+00 1.29E-03 1.00E-02 8.PF-06463922 supplier 84E-05 two.34E-12 6.65E-04 five.64E-08 two.12E-02 2.15E-02 1.96E-02 1.00E+00 two.11E-03 7.12E-04 two.62E-02 3.55E-02 eight.37E-04 two.67E-02 2.05E-02 4.14E-02 three.18E-02 1.06E-04 2.53E-06 7.24E-03 two.91e-4 three.45e-4 4.53e-4 5.13e-4 6.97e-4 9.38e-4 1.09e-3 1.12e-3 1.25e-3 1.38e-3 1.53e-3 1.61e-3 1.65e-3 1.66e-3 1.69e-3 1.79e-3 1.86e-3 2.32e-3 2.68e-3 3.06e-3 3.22e-3 three.43e-3 5.63e-3 five.65e-3 6.84e-3 7.58e-3 eight.16e-3 PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25112874 8.50e-3 eight.84e-3 9.12e-3 9.57e-3 9.99e-3 1.15e-2 1.17e-2 1.17e-2 1.26e-2 1.40e-2 1.88e-2 1.92e-2 1.93e-2 2.01e-2 2.23e-2 2.29e-2 2.34e-2 2.38e-2 two.67e-2 two.72e-2 2.72e-2 2.77e-2 2.93e-2 three.25e-2 three.43e-Cheung et al. The P-value with the term within the gene MeSHOP plus the disease MeSHOP are presented, and ordered by the difference within the two P-values.MEDLINE?through a lease in the NLM [64]. The CTD validation set was taken from the gene-disease relationships dataset [65].Availability of supply codeMedical Genetics, Centre for Molecular Medicine and Therapeutics at the Youngster and Family members Analysis Institute, University of British Columbia, 980 W. 28th Ave, Vancouver, V5Z 4H4, Canada. Authors' contributions All authors contributed for the design of your approach and also the analysis and interpretation in the data. WAC implemented and carried out the study. All authors read and approved the final manuscript. Competing interests The authors declare that they have no competing interests. Received: 28 April 2012 Revised: 11 September 2012 Accepted: 28 September 2012 Published: 28 PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25112874 September 2012 References 1.